Literature DB >> 28320044

Multiple concomitant oral cavity cancers: Incidence, management, and outcomes.

Huang-Kai Kao1, Mohamed Abdelrahman2, Yenlin Huang3, Chia-Hsuan Tsai4, Megias J Barrera1, Ngan-Ming Tsang5, Adam J Couves6, Ming-Huei Cheng1, Kai-Ping Chang7.   

Abstract

BACKGROUND: Little is known about the appropriate treatment and long-term survival of patients with multiple concomitant oral cavity cancers (MOC). The aim of this study was to clarify the clinicopathological features of MOC, to compare the prognosis of MOC patients with that of patients with single oral cavity cancers (SOC), and to describe reconstructive options based on the concept of economy in autologous tissue transfer.
METHODS: Data from 603 patients diagnosed with at least one squamous cell carcinoma of the oral cavity who underwent surgery for primary oral cavity cancers between 2006 and 2014 were reviewed retrospectively to identify MOC patients.
RESULTS: Among 603 cases of surgically resected primary oral cancers, 20 cases (3.3%) with MOC were identified. Patients with MOC did not differ from patients with SOC in age, and their index lesions did not differ in pT value, pN value, pathological stage, extracapsule spread, or perineural or bone invasion. The 5-year overall and disease-free survival rates for MOC and SOC cases were 72.6% versus 68.7%, and 65.3% versus 64.8%, respectively (P = 0.785 and 0.770, respectively). The anterolateral thigh flap was widely applied. According to its origin of blood supply, the reconstructive options of MOC patients with separated defects were classified and proposed.
CONCLUSIONS: MOC and SOC were similar in clinicopathological characteristics. The prognosis of patients with MOC was similar to that of patients with SOC. Resections were performed with curative intent. A multidisciplinary team management approach is essential for customized treatment in MOC patients.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  OSCC; head and neck; oral cancer; squamous cell carcinoma; synchronous

Mesh:

Year:  2017        PMID: 28320044     DOI: 10.1002/jso.24600

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

Review 1.  Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.

Authors:  Dante De Paz; Huang-Kai Kao; Yenlin Huang; Kai-Ping Chang
Journal:  Curr Oncol Rep       Date:  2017-08-10       Impact factor: 5.075

2.  Clinical Features of Oral Multiple Primary Carcinomas Compared with Oral Single Primary Carcinoma.

Authors:  Makoto Kawasaki; Takayuki Tamura; Yusei Harada; Nobuyuki Fujii; Rieko Doi; Isamu Kodani
Journal:  Yonago Acta Med       Date:  2020-09-14       Impact factor: 1.641

3.  Antiproliferative and Pro-Apoptotic Effects of a Phenolic-Rich Extract from Lycium barbarum Fruits on Human Papillomavirus (HPV) 16-Positive Head Cancer Cell Lines.

Authors:  Alberto Peraza-Labrador; Diana Marcela Buitrago; Ericsson Coy-Barrera; Sandra J Perdomo-Lara
Journal:  Molecules       Date:  2022-06-02       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.